CFIHX
Price
$73.09
Change
-$0.09 (-0.12%)
Updated
Sep 20 closing price
HRLYX
Price
$9.03
Change
-$0.03 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

CFIHX vs HRLYX

Header iconCFIHX vs HRLYX Comparison
Open Charts CFIHX vs HRLYXBanner chart's image
American Funds Capital Income Bldr F3
Price$73.09
Change-$0.09 (-0.12%)
VolumeN/A
CapitalizationN/A
Hartford Real Asset Y
Price$9.03
Change-$0.03 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CFIHX vs HRLYX Comparison Chart
Loading...
VS
CFIHX vs. HRLYX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIHX is a Buy and HRLYX is a Buy.

FUNDAMENTALS
Fundamentals
CFIHX has more cash in the bank: 110B vs. HRLYX (87.4M). HRLYX pays higher dividends than CFIHX: HRLYX (4.28) vs CFIHX (3.59). CFIHX was incepted earlier than HRLYX: CFIHX (8 years) vs HRLYX (14 years). HRLYX is a more actively managed with annual turnover of: 171.00 vs. CFIHX (106.00). HRLYX has a lower initial minimum investment than CFIHX: HRLYX (250000) vs CFIHX (1000000). CFIHX annual gain was more profitable for investors over the last year : 21.65 vs. HRLYX (8.54). CFIHX (34.15) and HRLYX (33.71) have equivalent 5 years return.
CFIHXHRLYXCFIHX / HRLYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD12.8774.258302%
Front LoadN/AN/A-
Min. Initial Investment1000000250000400%
Min. Initial Investment IRAN/AN/A-
Net Assets110B87.4M125,858%
Annual Yield % from dividends3.594.2884%
Returns for 1 year21.658.54253%
Returns for 3 years18.3615.24120%
Returns for 5 years34.1533.71101%
Returns for 10 yearsN/A20.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DC2.360.04
+1.72%
Dakota Gold Corp
K80.810.16
+0.20%
Kellanova
KELYA21.18-0.41
-1.90%
Kelly Services
ENOV43.67-1.35
-3.00%
Enovis Corp
PAVM1.59-0.06
-3.64%
PAVmed